AI assistant
MIMEDX GROUP, INC. — Director's Dealing 2025
Mar 5, 2025
32206_dirs_2025-03-05_e1dd335e-4d98-41ce-9a23-1be2d2f8eb14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2025-03-03
Reporting Person: DOUG RICE (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-03 | Common Stock | A | 45929 | — | Acquired | 200773 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | Stock Options | $8.30 | A | 36486 | Acquired | 2032-03-03 | Common Stock (36486) | Direct |
Footnotes
F1: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
F2: Includes an aggregate of 6,915 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan.
F3: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.